BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20465157)

  • 1. Influence of admission plasma glucose level on short- and long-term prognosis in patients with ST-segment elevation myocardial infarction.
    Mladenović V; Zdravković V; Jović M; Vucić R; Irić-Cupić V; Rosić M
    Vojnosanit Pregl; 2010 Apr; 67(4):291-5. PubMed ID: 20465157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction: insights from contrast-enhanced magnetic resonance imaging.
    Eitel I; Hintze S; de Waha S; Fuernau G; Lurz P; Desch S; Schuler G; Thiele H
    Circ Cardiovasc Imaging; 2012 Nov; 5(6):708-18. PubMed ID: 23051889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of admission blood glucose levels on the short term mortality in patients with acute ST-segment elevation myocardial infarction].
    Yang YM; Liu Y; Zhu J; Tan HQ; Liang Y; Li Y; Li JD; Zhang Y; Liu LS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1230-3. PubMed ID: 19595174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of admission blood glucose on prognosis of ST-segment elevation myocardial infarction patients with or without known diabetes].
    Liu Y; Yang YM; Zhu J; Tan HQ; Liang Y; Liu LS; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):590-4. PubMed ID: 19961726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
    García-García C; Subirana I; Sala J; Bruguera J; Sanz G; Valle V; Arós F; Fiol M; Molina L; Serra J; Marrugat J; Elosua R
    Am J Cardiol; 2011 Oct; 108(8):1061-7. PubMed ID: 21791326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.
    Rasoul S; Ottervanger JP; Bilo HJ; Timmer JR; van 't Hof AW; Dambrink JH; Dikkeschei LD; Hoorntje JC; de Boer MJ; Zijlstra F
    Neth J Med; 2007 Mar; 65(3):95-100. PubMed ID: 17387235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of admission blood glucose level on the prognosis of ST-segment elevation myocardial infarction].
    Liu Y; Yang YM; Zhu J; Tan HQ; Liang Y; Liu LS; Li Y
    Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):465-8. PubMed ID: 19954040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction.
    de Mulder M; van der Ploeg T; de Waard GA; Boersma E; Umans VA
    Cardiology; 2011; 120(4):227-34. PubMed ID: 22343543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of first 24 hours mean blood glucose level on the prognosis of hospitalized patients with ST-segment elevation myocardial infarction].
    Yang YM; Liu Y; Zhu J; Tan HQ; Liang Y; Liu LS; Li JD; Zhang Y;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1065-72. PubMed ID: 21215138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry).
    Naber CK; Mehta RH; Jünger C; Zeymer U; Wienbergen H; Sabin GV; Erbel R; Senges J; Gitt A
    Am J Cardiol; 2009 Mar; 103(5):583-7. PubMed ID: 19231316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
    Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
    Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of early repolarization on admission electrocardiography is associated with long-term mortality and MACE in patients with STEMI undergoing primary percutaneous intervention.
    Ozcan KS; Güngör B; Tatlısu MA; Osmonov D; Ekmekçi A; Çalık AN; Aruğarslan E; Zengin A; Bolca O; Eren M; Erdinler İ
    J Cardiol; 2014 Sep; 64(3):164-70. PubMed ID: 24508178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
    Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
    Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
    Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F;
    Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.